Single Ascending Dose Study of ATH-097 in Healthy Participants

Clinical trial NCT07640269 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07640269
Sponsor: Atheron Therapeutics, Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

This is a Phase I Study Conducted in Healthy Volunteers

Start date: 2026-07-06
Primary completion: 2026-10-20
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.